ROCKWELL MEDICAL, INC.·4

Sep 8, 6:36 PM ET

COOPER JOHN G 4

4 · ROCKWELL MEDICAL, INC. · Filed Sep 8, 2017

Insider Transaction Report

Form 4
Period: 2017-09-05
Transactions
  • Award

    Stock Appreciation Right

    2017-09-05+23,00023,000 total
    Exercise: $6.45Exp: 2027-09-05Common Stock (23,000 underlying)
Footnotes (1)
  • [F1]This grant vests upon the earliest to occur of any of the following (a) reported net sales of the company in any four consecutive calendar quarters equals or exceeds $100,000,000, (b) the market capitalization of the company is greater than $600,000,000 for ten consecutive trading days, (c) the Centers for Medicare & Medicaid Services assign the company transitional add on reimbursement payment status for the drug product, Triferic, or (d) immediately prior to a change in control. This grant can only be settled in cash.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION